NA
Nanobiotix
🇬🇧XLON.0QAVUnited KingdomHealthcare
€29.98EURdown -0.98 (-3.17%)ClosedEnd of day11:03 PM
Price€29.98-0.98 (-3.17%)
Profile
- Healthcare
- Biotechnology
- United Kingdom
Identity
- Exchange
- London Stock Exchange . XLON
- Type
- Stock
- ISIN
- FR0011341205
- CUSIP
- Not reported
Company
- Employees
- 100
- Headquarters
- Paris, United States
- Website
- https://www.nanobiotix.com
- CEO
- Dr. Laurent Levy Ph.D.
Market
- Shares outstanding
- 19.6M
- Market cap
- €588.04M
Highlights
- Market cap
- €607.26M
- EPS LTM
- -€0.50
- P/E LTM
- -39.40
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- €29.64M
- Net income
- -€23.96M
- Gross margin
- Not reported
- Free cash flow
- -€33.97M
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.